Immune Cell Dysfunction, Not Absence, Marks Skin Cancer Risk
Nonmelanoma skin cancer in immunosuppressed patients reflects immune cell dysfunction, not absence — a shift that could reshape surveillance and therapy.
Topic
Topic
Nonmelanoma skin cancer in immunosuppressed patients reflects immune cell dysfunction, not absence — a shift that could reshape surveillance and therapy.
PFAS exposure is associated with elevated nonmelanoma skin cancer risk, with the strongest signal in older adults, AJMC reports —…
GentleCure nonsurgical image-guided radiotherapy has treated its 150,000th patient for common skin cancer, marking a milestone in…